Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Advances in OncologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Soft-tissue sarcoma in adults: An update on the current state of histiotype-specific management in an era of personalized medicine.CA Cancer J Clin. 2020; 70: 200-229
- Soft Tissue Tumours.in: 5th edition. WHO Classification of Tumours of soft tissue and bone. 3. IARC Publications, 2020
- Lessons learned from the study of 10,000 patients with soft tissue sarcoma.Ann Surg. 2014; 260: 416-421
- Neoadjuvant and adjuvant strategies in retroperitoneal sarcoma.Eur J Surg Oncol. 2018; 44: 571-579
- Variability in Patterns of Recurrence After Resection of Primary Retroperitoneal Sarcoma (RPS): A Report on 1007 Patients From the Multi-institutional Collaborative RPS Working Group.Ann Surg. 2016; 263: 1002-1009
- Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group.Ann Surg Oncol. 2021; 28: 7873-7888
- Preoperative or postoperative radiotherapy versus surgery alone for retroperitoneal sarcoma: a case-control, propensity score-matched analysis of a nationwide clinical oncology database.Lancet Oncol. 2016; 17: 966-975
- The Benefit of Adjuvant Radiotherapy in High-grade Nonmetastatic Retroperitoneal Soft Tissue Sarcoma: A SEER Analysis.Am J Clin Oncol. 2018; 41: 274-279
- Efficacy of Postoperative Radiotherapy Using Modern Techniques in Patients with Retroperitoneal Soft Tissue Sarcoma.Yonsei Med J. 2018; 59: 1049-1056
- Multimodality local therapy for retroperitoneal sarcoma.Int J Radiat Oncol Biol Phys. 2012; 82: 1128-1134
- Combined management of retroperitoneal sarcoma with dose intensification radiotherapy and resection: long-term results of a prospective trial.Radiother Oncol. 2014; 110: 165-171
- Intraoperative radiotherapy in retroperitoneal sarcomas. Final results of a prospective, randomized, clinical trial.Arch Surg. 1993; 128: 402-410
- Significance of intraoperative radiation therapy and high cumulative radiation doses in retroperitoneal soft tissue sarcoma.Eur J Surg Oncol. 2020; 46: 905-913
- Intraoperative electron-beam therapy for primary and recurrent retroperitoneal soft-tissue sarcoma.Int J Radiat Oncol Biol Phys. 2006; 65: 773-779
- Use of intraoperative electron beam radiotherapy in the management of retroperitoneal soft tissue sarcomas.Int J Radiat Oncol Biol Phys. 2002; 52: 469-475
- Long-term results of intraoperative electron beam radiotherapy for primary and recurrent retroperitoneal soft tissue sarcoma.Int J Radiat Oncol Biol Phys. 2001; 50: 127-131
- A clinical phase I/II trial to investigate preoperative dose-escalated intensity-modulated radiation therapy (IMRT) and intraoperative radiation therapy (IORT) in patients with retroperitoneal soft tissue sarcoma.BMC Cancer. 2012; 12: 287
- Clinical phase I/II trial to investigate preoperative dose-escalated intensity-modulated radiation therapy (IMRT) and intraoperative radiation therapy (IORT) in patients with retroperitoneal soft tissue sarcoma: interim analysis.BMC Cancer. 2014; 14: 617
- American Brachytherapy Society consensus statement for soft tissue sarcoma brachytherapy.Brachytherapy. 2017; 16: 466-489
- In response to: “Intraoperative radiation therapy (IORT) for soft tissue sarcoma – ESTRO IORT task force/ACROP recommendations”.Radiother Oncol. 2021; 154: 170-171
- Intraoperative radiation therapy (IORT) for soft tissue sarcoma - ESTRO IORT Task Force/ACROP recommendations.Radiother Oncol. 2020; 150: 293-302
- Long-term Oncologic Outcomes After Neoadjuvant Radiation Therapy for Retroperitoneal Sarcomas.Ann Surg. 2015; 262: 163-170
- Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate- or high-grade retroperitoneal soft tissue sarcoma.Ann Surg Oncol. 2006; 13: 508-517
- Retroperitoneal sarcomas: combined modality treatment approaches.Curr Opin Oncol. 2002; 14: 400-405
- Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial.Lancet Oncol. 2020; 21: 1366-1377
- A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma.Cancer. 2008; 113: 573-581
- Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.J Clin Oncol. 1994; 12: 1137-1149
- Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial.Lancet Oncol. 2012; 13: 1045-1054
- A synovial sarcoma-specific preoperative nomogram supports a survival benefit to ifosfamide-based chemotherapy and improves risk stratification for patients.Clin Cancer Res. 2008; 14: 8191-8197
- Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up.Ann Oncol. 2021; 32: 1348-1365
- Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical Trial.JAMA Oncol. 2018; 4: 483-492
- Effectiveness of regional hyperthermia with chemotherapy for high-risk retroperitoneal and abdominal soft-tissue sarcoma after complete surgical resection: a subgroup analysis of a randomized phase-III multicenter study.Ann Surg. 2014; 260: 749-754
- MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data.Am J Surg Pathol. 2005; 29: 1340-1347
- Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts.Mol Cancer Ther. 2004; 3: 1427-1438
- Progression-Free Survival Among Patients With Well-Differentiated or Dedifferentiated Liposarcoma Treated With CDK4 Inhibitor Palbociclib: A Phase 2 Clinical Trial.JAMA Oncol. 2016; 2: 937-940
- Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial.Lancet Oncol. 2017; 18: 1493-1501
- Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma.BMC Cancer. 2018; 18: 913
- Neoadjuvant irradiation of retroperitoneal soft tissue sarcoma with ions (Retro-Ion): study protocol for a randomized phase II pilot trial.Trials. 2021; 22: 134
Article info
Publication history
Published online: April 07, 2022
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
